SB-258,719
Prijeđi na navigaciju
Prijeđi na pretragu
| |||
| (IUPAC) ime | |||
|---|---|---|---|
| (1R)-3,N-dimetil-N-[1-metil-3-(4-metilpiperidin-1-il)propil]benzenesulfonamid | |||
| Klinički podaci | |||
| Identifikatori | |||
| CAS broj | 195199-95-2 | ||
| ATC kod | nije dodeljen | ||
| PubChem[1][2] | 5312148 | ||
| ChemSpider[3] | 4471578 | ||
| ChEMBL[4] | CHEMBL12264 
| ||
| Hemijski podaci | |||
| Formula | C18H32N2O2S | ||
| Mol. masa | 340,523 g/mol | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | |||
SB-258,719 je lek koji deluje kao selektivni parcijalni inverzni agonist 5-HT7 receptora.[5] On je bio prvi identifikovani antagonist 5-HT7 receptora.[6] On se uglavnom upotrebljan u istraživanjima za demonstriranje potencijalne uloge 5-HT7 agonista kao potencijalnih analgetika, usled njegove sposobnosti da blokira analgetičke efekte raznih 5-HT7 agonista u miše modela.[7][8][9][10]
Reference[uredi | uredi kod]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.
- ↑ Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P (July 2004). „Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors”. European Journal of Pharmacology 495 (2-3): 97–102. DOI:10.1016/j.ejphar.2004.05.033. PMID 15249157.
- ↑ Forbes IT, Dabbs S, Duckworth DM, Jennings AJ, King FD, Lovell PJ, Brown AM, Collin L, Hagan JJ, Middlemiss DN, Riley GJ, Thomas DR, Upton N (February 1998). „(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist”. Journal of Medicinal Chemistry 41 (5): 655–7. DOI:10.1021/jm970519e. PMID 9513592.
- ↑ Brenchat A, Romero L, García M, Pujol M, Burgueño J, Torrens A, Hamon M, Baeyens JM, Buschmann H, Zamanillo D, Vela JM (February 2009). „5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice”. Pain 141 (3): 239–47. DOI:10.1016/j.pain.2008.11.009. PMID 19118950.
- ↑ Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, Akgül O, Kozak O, Kurt E, Aypar U (March 2010). „Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways”. Anesthesiology 112 (3): 696–710. DOI:10.1097/ALN.0b013e3181cd7920. PMID 20179508.
- ↑ Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, Portillo-Salido E, Pujol M, Montero A, Codony X, Burgueño J, Zamanillo D, Hamon M, Maldonado R, Vela JM (June 2010). „Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity”. Pain 149 (3): 483–94. DOI:10.1016/j.pain.2010.03.007. PMID 20399562.
- ↑ Brenchat A, Ejarque M, Zamanillo D, Vela JM, Romero L (August 2011). „Potentiation of Morphine Analgesia by Adjuvant Activation of 5-HT(7) Receptors”. Journal of Pharmacological Sciences 116 (4): 388–91. PMID 21778664.
